Displaying drugs 15001 - 15025 of 15256 in total
Sequifenadine
Experimental
Picloxydine
Experimental
Sulbentine
Experimental
Xibornol
Experimental
Guanoclor
Experimental
Clofibride
Experimental
Bisoxatin acetate
Experimental
Apratastat
Tmi 005 is under investigation in clinical trial NCT00095342 (Study Evaluating TMI-005 in Active Rheumatoid Arthritis).
Investigational
Ronifibrate
Experimental
Haloxazolam
Experimental
Illicit
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid
Experimental
Mosapramine
Experimental
CTS-21166
CTS-21166 is a small-molecule beta-secretase inhibitor, which is being developed as a disease-modifying treatment for Alzheimer's disease. CTS-21166 is the only BACE1 inhibitor that has passed Phase I clinical trial thus far. In 2008, CoMentis revealed this small compound as a transition-state analog inhibitor (structure is currently undisclosed) with excellent...
Investigational
Matched Description: … currently undisclosed) with excellent properties in brain penetration, selectivity, metabolic stability, and …
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Dipipanone
Experimental
Illicit
2,3,4,5,6-Pentafluorobenzyl Alcohol
Experimental
Balanol Analog 2
Experimental
Displaying drugs 15001 - 15025 of 15256 in total